Selected research
Market Outlook & Growth Opportunities
Global Rapid Sterility Testing Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Rapid Sterility Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Rapid Sterility Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Rapid Sterility Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Rapid Sterility Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Rapid Sterility Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Rapid Sterility Testing Service market include Nelson Labs, BioMérieux, Alcami, Sartorius, Reading Scientific Services Ltd, Mysterilab, Thermo Fisher Scientific, SGS SA and WuXiAppTec, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Rapid Sterility Testing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Rapid Sterility Testing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Rapid Sterility Testing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Rapid Sterility Testing Service market.
Rapid Sterility Testing Service Segment by Company
Nelson Labs
BioMérieux
Alcami
Sartorius
Reading Scientific Services Ltd
Mysterilab
Thermo Fisher Scientific
SGS SA
WuXiAppTec
Jiangsu Puxin Biomedicine Co., Ltd.
Eurofins Scientific
Merck
Charles River Laboratories
Rapid Sterility Testing Service Segment by Type
Membrane Filtration
Direct Inoculation
Rapid Sterility Testing Service Segment by Application
Hospital
Pharmaceutical Company
Laboratory
Others
Rapid Sterility Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Rapid Sterility Testing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Rapid Sterility Testing Service key companies, revenue, market share, and recent developments.
3. To split the Rapid Sterility Testing Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Rapid Sterility Testing Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Rapid Sterility Testing Service significant trends, drivers, influence factors in global and regions.
6. To analyze Rapid Sterility Testing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rapid Sterility Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rapid Sterility Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rapid Sterility Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rapid Sterility Testing Service industry.
Chapter 3: Detailed analysis of Rapid Sterility Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Rapid Sterility Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Rapid Sterility Testing Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Membrane Filtration
- Direct Inoculation
Applications
- Hospital
- Pharmaceutical Company
- Laboratory
- Others
Companies covered
- Nelson Labs
- BioMérieux
- Alcami
- Sartorius
- Reading Scientific Services Ltd
- Mysterilab
- Thermo Fisher Scientific
- SGS SA
- WuXiAppTec
- Jiangsu Puxin Biomedicine Co., Ltd.
- Eurofins Scientific
- Merck
- Charles River Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Rapid Sterility Testing Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Rapid Sterility Testing Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Rapid Sterility Testing Service Market Dynamics
- 2.1 Rapid Sterility Testing Service Industry Trends
- 2.2 Rapid Sterility Testing Service Industry Drivers
- 2.3 Rapid Sterility Testing Service Industry Opportunities and Challenges
- 2.4 Rapid Sterility Testing Service Industry Restraints
3 Rapid Sterility Testing Service Market by Company
- 3.1 Global Rapid Sterility Testing Service Company Revenue Ranking in 2025
- 3.2 Global Rapid Sterility Testing Service Revenue by Company (2021-2026)
- 3.3 Global Rapid Sterility Testing Service Company Ranking (2024-2026)
- 3.4 Global Rapid Sterility Testing Service Company Manufacturing Base and Headquarters
- 3.5 Global Rapid Sterility Testing Service Company Product Type and Application
- 3.6 Global Rapid Sterility Testing Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Rapid Sterility Testing Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Rapid Sterility Testing Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Rapid Sterility Testing Service Market by Type
- 4.1 Rapid Sterility Testing Service Type Introduction
- 4.1.1 Membrane Filtration
- 4.1.2 Direct Inoculation
- 4.2 Global Rapid Sterility Testing Service Sales Value by Type
- 4.2.1 Global Rapid Sterility Testing Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Rapid Sterility Testing Service Sales Value by Type (2021-2032)
- 4.2.3 Global Rapid Sterility Testing Service Sales Value Share by Type (2021-2032)
5 Rapid Sterility Testing Service Market by Application
- 5.1 Rapid Sterility Testing Service Application Introduction
- 5.1.1 Hospital
- 5.1.2 Pharmaceutical Company
- 5.1.3 Laboratory
- 5.1.4 Others
- 5.2 Global Rapid Sterility Testing Service Sales Value by Application
- 5.2.1 Global Rapid Sterility Testing Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Rapid Sterility Testing Service Sales Value by Application (2021-2032)
- 5.2.3 Global Rapid Sterility Testing Service Sales Value Share by Application (2021-2032)
6 Rapid Sterility Testing Service Regional Value Analysis
- 6.1 Global Rapid Sterility Testing Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Rapid Sterility Testing Service Sales Value by Region (2021-2032)
- 6.2.1 Global Rapid Sterility Testing Service Sales Value by Region: 2021-2026
- 6.2.2 Global Rapid Sterility Testing Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Rapid Sterility Testing Service Sales Value (2021-2032)
- 6.3.2 North America Rapid Sterility Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Rapid Sterility Testing Service Sales Value (2021-2032)
- 6.4.2 Europe Rapid Sterility Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Rapid Sterility Testing Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Rapid Sterility Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Rapid Sterility Testing Service Sales Value (2021-2032)
- 6.6.2 South America Rapid Sterility Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Rapid Sterility Testing Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Rapid Sterility Testing Service Sales Value Share by Country, 2025 VS 2032
7 Rapid Sterility Testing Service Country-level Value Analysis
- 7.1 Global Rapid Sterility Testing Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Rapid Sterility Testing Service Sales Value by Country (2021-2032)
- 7.2.1 Global Rapid Sterility Testing Service Sales Value by Country (2021-2026)
- 7.2.2 Global Rapid Sterility Testing Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Rapid Sterility Testing Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Rapid Sterility Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Rapid Sterility Testing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Nelson Labs
- 8.1.1 Nelson Labs Company Information
- 8.1.2 Nelson Labs Business Overview
- 8.1.3 Nelson Labs Rapid Sterility Testing Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Nelson Labs Rapid Sterility Testing Service Product Portfolio
- 8.1.5 Nelson Labs Recent Developments
- 8.2 BioMérieux
- 8.2.1 BioMérieux Company Information
- 8.2.2 BioMérieux Business Overview
- 8.2.3 BioMérieux Rapid Sterility Testing Service Revenue and Gross Margin (2021-2026)
- 8.2.4 BioMérieux Rapid Sterility Testing Service Product Portfolio
- 8.2.5 BioMérieux Recent Developments
- 8.3 Alcami
- 8.3.1 Alcami Company Information
- 8.3.2 Alcami Business Overview
- 8.3.3 Alcami Rapid Sterility Testing Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Alcami Rapid Sterility Testing Service Product Portfolio
- 8.3.5 Alcami Recent Developments
- 8.4 Sartorius
- 8.4.1 Sartorius Company Information
- 8.4.2 Sartorius Business Overview
- 8.4.3 Sartorius Rapid Sterility Testing Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Sartorius Rapid Sterility Testing Service Product Portfolio
- 8.4.5 Sartorius Recent Developments
- 8.5 Reading Scientific Services Ltd
- 8.5.1 Reading Scientific Services Ltd Company Information
- 8.5.2 Reading Scientific Services Ltd Business Overview
- 8.5.3 Reading Scientific Services Ltd Rapid Sterility Testing Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Reading Scientific Services Ltd Rapid Sterility Testing Service Product Portfolio
- 8.5.5 Reading Scientific Services Ltd Recent Developments
- 8.6 Mysterilab
- 8.6.1 Mysterilab Company Information
- 8.6.2 Mysterilab Business Overview
- 8.6.3 Mysterilab Rapid Sterility Testing Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Mysterilab Rapid Sterility Testing Service Product Portfolio
- 8.6.5 Mysterilab Recent Developments
- 8.7 Thermo Fisher Scientific
- 8.7.1 Thermo Fisher Scientific Company Information
- 8.7.2 Thermo Fisher Scientific Business Overview
- 8.7.3 Thermo Fisher Scientific Rapid Sterility Testing Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Thermo Fisher Scientific Rapid Sterility Testing Service Product Portfolio
- 8.7.5 Thermo Fisher Scientific Recent Developments
- 8.8 SGS SA
- 8.8.1 SGS SA Company Information
- 8.8.2 SGS SA Business Overview
- 8.8.3 SGS SA Rapid Sterility Testing Service Revenue and Gross Margin (2021-2026)
- 8.8.4 SGS SA Rapid Sterility Testing Service Product Portfolio
- 8.8.5 SGS SA Recent Developments
- 8.9 WuXiAppTec
- 8.9.1 WuXiAppTec Company Information
- 8.9.2 WuXiAppTec Business Overview
- 8.9.3 WuXiAppTec Rapid Sterility Testing Service Revenue and Gross Margin (2021-2026)
- 8.9.4 WuXiAppTec Rapid Sterility Testing Service Product Portfolio
- 8.9.5 WuXiAppTec Recent Developments
- 8.10 Jiangsu Puxin Biomedicine Co., Ltd.
- 8.10.1 Jiangsu Puxin Biomedicine Co., Ltd. Company Information
- 8.10.2 Jiangsu Puxin Biomedicine Co., Ltd. Business Overview
- 8.10.3 Jiangsu Puxin Biomedicine Co., Ltd. Rapid Sterility Testing Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Jiangsu Puxin Biomedicine Co., Ltd. Rapid Sterility Testing Service Product Portfolio
- 8.10.5 Jiangsu Puxin Biomedicine Co., Ltd. Recent Developments
- 8.11 Eurofins Scientific
- 8.11.1 Eurofins Scientific Company Information
- 8.11.2 Eurofins Scientific Business Overview
- 8.11.3 Eurofins Scientific Rapid Sterility Testing Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Eurofins Scientific Rapid Sterility Testing Service Product Portfolio
- 8.11.5 Eurofins Scientific Recent Developments
- 8.12 Merck
- 8.12.1 Merck Company Information
- 8.12.2 Merck Business Overview
- 8.12.3 Merck Rapid Sterility Testing Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Merck Rapid Sterility Testing Service Product Portfolio
- 8.12.5 Merck Recent Developments
- 8.13 Charles River Laboratories
- 8.13.1 Charles River Laboratories Company Information
- 8.13.2 Charles River Laboratories Business Overview
- 8.13.3 Charles River Laboratories Rapid Sterility Testing Service Revenue and Gross Margin (2021-2026)
- 8.13.4 Charles River Laboratories Rapid Sterility Testing Service Product Portfolio
- 8.13.5 Charles River Laboratories Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst